Translocation (3;21) in Philadelphia-Positive Cml Blast Crisis in a Boy with Severe Skeletal Changes

References

• Rowley J D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Gimesa staining. Nature 1973; 243: 290–91
   PubMed Web of Science ®Google Scholar
• Pugh W C, Pearson M, Vardiman J W, Rowley J D. Philadelphia chromosome-negative chronic myelogenous leukemia: A morphologic reassessment. Br J Haematol 1985; 60: 457–67
   PubMed Web of Science ®Google Scholar
• Shtivelman E, Lifshitz B, Gale R P, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 1985; 315: 550–5
   PubMed Web of Science ®Google Scholar
• Grosfeld G, Verwoerd T, van Agthoven T. The myelo-cytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr-abl transcript. Mol Cell Biol 1986; 6: 607–16
   PubMedGoogle Scholar
• Davis R L, Konopka J B, Witte O N. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol 1985; 5: 204
   PubMed Web of Science ®Google Scholar
• Rowley J D, Testa J R. Chromosomal abnormalities in malignant hematologic disease. Adv Cancer Res 1982; 36: 103–48
   PubMed Web of Science ®Google Scholar
• Mitelman F, Levan G. Clustering of aberrations to specific chromosomes in human neoplasms III. Incidence and geographic distribution of chromosome aberrations in 856 cases. Hereditas 1970; 89: 207–32
   Google Scholar
• Rubin C M, Larson R A, Bitter M A. Association of chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood 1987; 70: 1338–48
   PubMed Web of Science ®Google Scholar
• Diez-Martin J L, Dewald G W, Pierre R V. Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia. Am J Hematol 1988; 27: 194–203
   PubMed Web of Science ®Google Scholar
• Aventin A, Mecucci C, Van den Berghe H. Blastic phase of Ph1-positive chronic myeloid leukemia and t(3;21). Blood 1988; 72: 369
   PubMed Web of Science ®Google Scholar
• Coyle T, Najfeld V. Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis. Am J Hematol 1988; 27: 56–9
   PubMed Web of Science ®Google Scholar
• Lafage M, Sainty D., Adriaansen H J. Translocation (3;21) in Philadelphia positive chronic myeloid leukemia: high resolution chromosomal analysis and immunological study on five new cases. Leukemia 1989; 3: 554–9
   PubMedGoogle Scholar
• Dewald G W, Broderick D J, Tom W W, Hagstrom J E, Pierre R V. The efficiency of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 1985; 18: 1
   PubMed Web of Science ®Google Scholar
• Harnden D G, Klinger H P. ISCN—An international system for human cytogenetic nomenclature. Karger, New York 1985, published in collabration with Cytogenet Cell Genet
   Google Scholar
• Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503
   PubMed Web of Science ®Google Scholar
• Rigby P W, Bieckmann M, Rhodes C, Berg P. Labeling de-oxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase. I. J Mol Biol 1977; 113: 237
   PubMed Web of Science ®Google Scholar
• Chambner B A, Haskell C M, Canellous G P. Destructive bone lesions in chronic granulocytic leukemia. Medicine 1969; 48: 401–10
   PubMedGoogle Scholar
• Braunstein E M, Hammond B, Schnitzer B. Bone destruction in myelogenous marrow crisis. J Can Assoc Radiol 1980; 31: 69–70
   PubMedGoogle Scholar
• Walter R M, Greenbro B R. Hypercalcemia in the accelerated phase of chronic myelogenous leukemia. Cancer 1980; 46: 1174
   PubMed Web of Science ®Google Scholar
• Sandberg A A, Gemmil R M, Hecht B K, Hecht F. The Philadelphia chromosome: a model of cancer and molecular cytogenetics. Cancer Genet Cytogenet 1986; 21: 129–46
   PubMed Web of Science ®Google Scholar
• Bertram C R, Carbonell F. Bcr rearrangement in Ph-negative CML. Cancer Genet Cytogenet 1986; 21: 183–4
   PubMedGoogle Scholar